India's Cipla gets tentative U.S. nod for HIV tablets

MUMBAI Thu Oct 18, 2012 8:42am BST

Related Topics

Quotes

   

MUMBAI (Reuters) - Indian drugmaker Cipla has received a tentative U.S. FDA approval for its HIV treatment tablets, which have a combination of lamivudine, nevirapine and zidovudine drugs, the drug regulator's website showed.

Cipla sells the combination drug under the brand name 'Duovir N' outside the United States.

The company plans to use a different brand name in the U.S. for this drug, S. Radhakrishnan, a director on Cipla board told Reuters.

(Reporting by Kaustubh Kulkarni; Editing by Anupama Dwivedi)

FILED UNDER:
Photo

After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.